Related Experiment Videos
Activation of mucociliary function in chronic rhinitis: a placebo-controlled study.
J Nuutinen1, P Karttunen, M Silvasti
1Department of Otolaryngology, University of Kuopio, Finland.
Archives of Oto-Rhino-Laryngology
|January 1, 1988
Summary
HR-6, a solution with adenosine triphosphate, improved nasal mucociliary activity in chronic rhinitis patients. More patients preferred HR-6 over placebo for symptom relief, suggesting its therapeutic potential.
Area of Science:
- Otolaryngology
- Pharmacology
Background:
- Chronic rhinitis often involves impaired nasal mucociliary activity.
- Nasal mucociliary clearance is crucial for respiratory health.
Purpose of the Study:
- To evaluate the efficacy of HR-6 (adenosine triphosphate) in improving nasal mucociliary activity and rhinitis symptoms.
- To compare HR-6 with a placebo in a randomized crossover study.
Main Methods:
- 11 patients with chronic rhinitis participated in a randomized, crossover trial.
- Nasal mucociliary activity was measured using a radioisotopic method.
- Patients received HR-6 (0.5 or 5 mg/ml) or placebo for 10 days, followed by 4-day wash-out periods.
Main Results:
- All patients exhibited impaired mucociliary activity (mean 3.2 mm/min).
- HR-6 improved mucociliary activity by 1.9-2.1 mm/min compared to placebo (1.4 mm/min).
- Six patients preferred HR-6 for symptom relief; none preferred placebo.
Conclusions:
- HR-6 demonstrates potential in improving impaired mucociliary function in chronic rhinitis.
- Further long-term studies are warranted to confirm HR-6's therapeutic benefits.